Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Operating Expenses (2016 - 2026)

Pharma-Bio Serv filings provide 16 years of Operating Expenses readings, the most recent being $816909.0 for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 5.04% to $816909.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $3.5 million, a 5.03% decrease, with the full-year FY2025 number at $3.5 million, down 6.73% from a year prior.
  • Operating Expenses hit $816909.0 in Q1 2026 for Pharma-Bio Serv, down from $882207.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.1 million in Q3 2023 to a low of $816909.0 in Q1 2026.
  • Median Operating Expenses over the past 5 years was $931850.0 (2024), compared with a mean of $930807.7.
  • Biggest five-year swings in Operating Expenses: tumbled 85.08% in 2022 and later grew 15.56% in 2023.
  • Pharma-Bio Serv's Operating Expenses stood at $939683.0 in 2022, then rose by 4.46% to $981570.0 in 2023, then dropped by 10.28% to $880700.0 in 2024, then grew by 0.17% to $882207.0 in 2025, then fell by 7.4% to $816909.0 in 2026.
  • The last three reported values for Operating Expenses were $816909.0 (Q1 2026), $882207.0 (Q4 2025), and $888139.0 (Q3 2025) per Business Quant data.